Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Research Consortium (CRC) Phase II Study of Subcutaneous Campath-1H in Patients With B-Cell Chronic Lymphocytic Leukemia and Residual Disease After Chemotherapy

NCT00800943 is registered in ClinicalTrials.gov with Chronic Lymphocytic Leukemia Research Consortium as lead sponsor.

NCT NCT00800943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00800943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Research Consortium (CRC) Phase II Study of Subcutaneous Campath-1H in Patients With B-Cell Chronic Lymphocytic Leukemia and Residual Disease After Chemotherapy
Lead sponsor
Chronic Lymphocytic Leukemia Research Consortium
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2003
Completion date
August 31, 2010
Enrollment
31 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell chronic lymphocytic leukemia